The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.
Toolkits/Methodology
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Request for Proposals (RFP)
Sample landscaping services request for proposal (RFP).
Advisory
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.